In coherence with observations on the risk that mutations in different genes pose for the progression of age-related CH into AML47,48, we found mutations of TP53 (significantly), IDH2 and several splicing factors (not significantly) overrepresented among tAML cases (Fig. 4b). This evidence concerns the gene TP53 and cyclic hematopoiesis.